Literature DB >> 21241696

LKB1 loss of function studied in vivo.

Boris Y Shorning1, Alan R Clarke.   

Abstract

Recent developments have placed the serine/threonine kinase LKB1 on the crossroads linking energy metabolism, cell structure and cancer progression and that its deletion can affect tumorigenesis, metastasis, cell adhesion and polarity. LKB1 can regulate a host of different functions which all have potential to impact upon the initiation and progression of neoplastic disease. To understand the phenotypic consequences of LKB1 loss in a range of different settings, a number of animal models of loss of function have been generated and analyzed. In this review we summarize recent data generated from a range of these models, which reveal clear tissue specific differences in LKB1 function in vivo and in the consequences of its loss.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21241696     DOI: 10.1016/j.febslet.2011.01.019

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Metabolic regulator LKB1 is crucial for Schwann cell-mediated axon maintenance.

Authors:  Bogdan Beirowski; Elisabetta Babetto; Judith P Golden; Ying-Jr Chen; Kui Yang; Richard W Gross; Gary J Patti; Jeffrey Milbrandt
Journal:  Nat Neurosci       Date:  2014-09-07       Impact factor: 24.884

2.  Altered LKB1/AMPK/TSC1/TSC2/mTOR signaling causes disruption of Sertoli cell polarity and spermatogenesis.

Authors:  Pradeep S Tanwar; Tomoko Kaneko-Tarui; LiHua Zhang; Jose M Teixeira
Journal:  Hum Mol Genet       Date:  2012-07-12       Impact factor: 6.150

3.  Post-translational regulation contributes to the loss of LKB1 expression through SIRT1 deacetylase in osteosarcomas.

Authors:  Nadège Presneau; Laure Alice Duhamel; Hongtao Ye; Roberto Tirabosco; Adrienne M Flanagan; Malihe Eskandarpour
Journal:  Br J Cancer       Date:  2017-06-20       Impact factor: 7.640

4.  Association between STK11 Gene Polymorphisms and Coronary Artery Disease in Type 2 Diabetes in Han Population in China.

Authors:  Xiaowei Ma; Ge Bai; Difei Lu; Linjuan Huang; Jianwei Zhang; Ruifen Deng; Shan Ding; Nan Gu; Xiaohui Guo
Journal:  J Diabetes Res       Date:  2017-02-28       Impact factor: 4.011

5.  LKB1 specifies neural crest cell fates through pyruvate-alanine cycling.

Authors:  Anca G Radu; Sakina Torch; Florence Fauvelle; Karin Pernet-Gallay; Anthony Lucas; Renaud Blervaque; Véronique Delmas; Uwe Schlattner; Laurence Lafanechère; Pierre Hainaut; Nicolas Tricaud; Véronique Pingault; Nadège Bondurand; Nabeel Bardeesy; Lionel Larue; Chantal Thibert; Marc Billaud
Journal:  Sci Adv       Date:  2019-07-17       Impact factor: 14.136

6.  Loss of LKB1 Protein Expression Correlates with Increased Risk of Recurrence and Death in Patients with Resected, Stage II or III Colon Cancer.

Authors:  Maria Sfakianaki; Chara Papadaki; Maria Tzardi; Maria Trypaki; Sardar Alam; Eleni D Lagoudaki; Ippokratis Messaritakis; Odysseas Zoras; Dimitris Mavroudis; Vassilis Georgoulias; John Souglakos
Journal:  Cancer Res Treat       Date:  2019-03-20       Impact factor: 4.679

7.  LKB1 loss cooperating with BRAF V600E promotes melanoma cell invasion and migration by up-regulation MMP-2 via PI3K/Akt/mTOR pathway.

Authors:  Weiming Zhang; Li Yin; Guoxin Song; Xue Han; Zhiqiang Yin; Dan Luo
Journal:  Oncotarget       Date:  2017-12-05

8.  Lkb1 deficiency confers glutamine dependency in polycystic kidney disease.

Authors:  Ebony M Flowers; Jessica Sudderth; Lauren Zacharias; Glenda Mernaugh; Roy Zent; Ralph J DeBerardinis; Thomas J Carroll
Journal:  Nat Commun       Date:  2018-02-26       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.